Medical Devices Series A Investors & VC Firms
1128 firms in this list, with a median first check of $500K. 245 of them lead rounds. Generated from verified public data and updated continuously.
NYBC Ventures
New YorkSeed–Series B
8 people
SyndicateRoom
CambridgePre-Seed–Series A
5 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
2 people
Joy Capital
BeijingSeed–Growth
6 people
Criteria Bio Ventures
BarcelonaSeed–Series B
7 people
Cure Kids Ventures
AucklandSeed–Series A
6 people
Red Bear Angels
IthacaSeed–Series A$100K – $1M
3 people
New Leaf Venture Partners
New YorkSeed–Series B
7 people
Vespucci Partners
BudapestSeed–Series A$648K – $4.9M
5 people
Cycad Group LLC
Santa BarbaraSeed–Late Stage
4 people
Launch Capital
TorontoSeed–Series B
3 people
Newpath Partners
BostonSeed–Series A$50K – $10M
3 people
Simpact Ventures
WarszawaPre-Seed–Series A$500K – $2M
6 people
Claremont Creek Ventures
OaklandSeed–Late Stage$500K – $3M
5 people
Med-Fine Capital
ShanghaiSeed–Series A
8 people
Pointguard Ventures
Los AltosSeries A–Series B$2M – $10M
5 people
Linden Capital
ChicagoPre-Seed–Series A
2 people
Future Positive Capital
Pre-Seed–Series A
4 people
Mohr Davidow Ventures
San MateoSeed–Late Stage$200K – $4M
7 people
Montis Capital
WarsawSeries A–Growth$1.6M – $5.5M
4 people
Shoni Health Ventures
Ramat GanSeed–Growth
10 people
Averin Capital
New YorkSeed–Growth
9 people
Invest Michigan
NorthvillePre-Seed–Series A$100K – $250K
3 people
Toledo Capital AG
ZürichSeed–Late Stage
12 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)Series A Investors & VC Firms in Global (2211)
Data sourced from public filings and firms' own websites — see our methodology.



















































































